Advertisement

Hemodynamic Sensors in Heart Failure Devices

  • Chu-Pak Lau
  • Hung-Fat Tse

Keywords

Heart Rate Variability Right Ventricular Cardiac Resynchronization Therapy Pulmonary Capillary Wedge Pressure Right Ventricular Pace 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lau CP. The range of sensors and algorithms used in rate adaptive cardiac pacing. Pacing Clin Electrophysiol 1992;15:1177–211.PubMedCrossRefGoogle Scholar
  2. 2.
    Karlof I. Haemodynamic effect of atrial triggered versus fixed rate pacing at rest and during exercise in complete heart block. Acta Med Scand 1975;197:195–206.PubMedGoogle Scholar
  3. 3.
    Greenberg B, Chatterjee K, Parmley WW, et al. The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 1979;98: 742–51.PubMedCrossRefGoogle Scholar
  4. 4.
    Vollmann D, Luthje L, Schott P, et al. Biventricular pacing improves the blunted force-frequency relation present during univentricular pacing in patients with heart failure and conduction delay. Circulation 2006;113:953–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Feldman MD, Alderman JD, Aroesty JM, et al. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J Clin Invest 1988;82:1661–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Tse HF, Siu CW, Lee KLF, et al. The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:2292–7.PubMedCrossRefGoogle Scholar
  7. 7.
    American Heart Association. Heart disease and Stroke Statistics. 2006 update. www.americanheart.org/presents.jhtml?identifier=3036350.Google Scholar
  8. 8.
    Felker MG, Adams KF, Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 2003;145:518–25.CrossRefGoogle Scholar
  9. 9.
    Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99–104.PubMedCrossRefGoogle Scholar
  10. 10.
    Kadhiressan VA, Pastore J, Auricchio A, et al. A novel method—the activity log index—for monitoring physical activity of patients with heart failure. Am J Cardiol 2002;89:1435–7.CrossRefGoogle Scholar
  11. 11.
    Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004;110:2389–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Carlson G, Girouard S, Schlegl M, et al. Three-dimensional heart rate variability diagnostic for monitoring heart failure through an implantable device. J Cardiovasc Electrophysiol 2004;15:506.PubMedCrossRefGoogle Scholar
  13. 13.
    Lau CP, Tai YT, Lee IS, et al. Utility of an implantable right ventricular oxygen saturation-sensing pacemaker for ambulatory cardiopulmonary monitoring. Chest 1995;107:1089–94.PubMedGoogle Scholar
  14. 14.
    Ohlsson A, Kubo SH, Steinhaus D, et al. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. Eur Heart J 2001;22:942–54.PubMedCrossRefGoogle Scholar
  15. 15.
    Reynolds DW, Bartelt N, Taepke R, et al. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 1995;25:1176–82.PubMedCrossRefGoogle Scholar
  16. 16.
    Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynamics in heart failure: Clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003;41:565–71.PubMedCrossRefGoogle Scholar
  17. 17.
    Bouge RC. COMPASS-HF study. Late breaking news session. American College of Cardiology Conference, Orlando, Florida, 2005. (Medscape. Com/Viewarticle/50 1568.)Google Scholar
  18. 18.
    Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Osswald S, Cron T, Gradel P, et al. Close-loop stimulation using intracardiac impedance as a sensor principle: Correlation of right ventricular dP/dt max and intracardiac impedance during dobutamine stress test. Pacing Clin Electrophysiol 2000;23:1502.Google Scholar
  20. 20.
    Plicchi G, Marcelli E, Parlapiano MB, et al. PEA I and PEA II based implantable haemodynamic monitor: Preclinical studies in sheep. Europace 2002;4:49–54.PubMedCrossRefGoogle Scholar
  21. 21.
    Bordachar P, Garrigue S, Reuter S, et al. Hemodynamic assessment of right, left, and biventricular pacing by peak endocardial acceleration and echocardiography in patients with end-stage heart failure. Pacing Clin Electrophysiol 2000;23(11 Pt 2);1726–30.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Chu-Pak Lau
  • Hung-Fat Tse

There are no affiliations available

Personalised recommendations